Cumberland Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Tennessee, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1600 West End Ave Ste 1300, Nashville, T...Phone Number
(615) 255-0068Website
www.cumberlandpharma.comRevenue
$44.3 MillionStock Symbol
CPIXIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc. is an American specialty pharmaceutical company that develops, acquires, and commercializes a portfolio of branded prescription medicines designed to improve the quality of patient care. Its products include a range of FDA-approved prescription drugs for hospital acute care, gastroenterology, oncology, and related clinical segments. The companys mission is to work collaboratively to deliver unique therapeutic products that address unmet medical needs and enhance patient outcomes both in the United States and through select international partnerships. Cumberland is publicly listed on the NASDAQ stock exchange under the ticker CPIX and is headquartered in Nashville, Tennessee.Explore more
Cumberland Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cumberland Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cumberland Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Cumberland Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Cumberland Pharmaceuticals has new funding data
Earning: See what the market has to say on Cumberland Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Cumberland Pharmaceuticals
Cumberland Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Cumberland Pharmaceuticals is spiking on competitors!
Check if Cumberland Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Cumberland Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Cumberland Pharmaceuticals
Compare insights from companies similar to Cumberland Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cumberland Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cumberland Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cumberland Pharmaceuticals.
Cumberland Pharmaceuticals financials insights
Gather financial insights about Cumberland Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Stock Offering
$85M
2020
Debt
$2M
Cumberland Pharmaceuticals Tech Stack
A closer look at the technologies used by Cumberland Pharmaceuticals
See more technologies
Most Recent Scoops
Earnings
Event
Earnings, Events, Finance
Person-Based
Earnings, Finance, Financing & Debt
Person-Based
Board of Directors
Person-Based
Events, Medical Research
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Cumberland Pharmaceuticals News & Media
Cumberland Pharmaceuticals Q2 Earnings Call Highlights
Cumberland Pharmaceuticals (NASDAQ:CPIX) reported a second-quarter operating loss of $3.1 million as it prepared to transition from a commercial-stage specialty pharmaceutical company into an innovation-focused biopharmaceutical business following the sale of its branded U.S. commercial portfolio toCUMBERLAND PHARMACEUTICALS REPORTS COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
$100 million Strategic Transaction Closed Special Shareholder Dividend Funded Advancing Late Stage Clinical Pipeline NASHVILLE, Tenn., Aug. 4, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), an innovation-focused biopharmaceutical company, announced today its second...CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
NASHVILLE, Tenn., July 28, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), an innovation-focused biopharmaceutical company committed to developing new products for rare diseases, announced today that it will provide a company update with second quarter 2026 financial...CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE
Record Date is July 10, 2026 & Payment Date is July 31,2026 Corporate and Insider Share Purchase Initiatives to Continue NASHVILLE, Tenn., July 13, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), an innovation-focused biopharmaceutical company developing new products...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cumberland Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Cumberland Pharmaceuticals Inc. is an American specialty pharmaceutical company that develops, acquires, and commercializes a portfolio of branded prescription medicines designed to improve the quality of patient care. Its products include a range of FDA-approved prescription drugs for hospital acute care, gastroenterology, oncology, and related cl... Read More
